Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson's Disease

about

Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson's Disease

Item

http://www.wikidata.org/entity/Q57490051

description

article

@en

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Epothilone B Benefits Nigral D ...... e Model of Parkinson's Disease

@en

Epothilone B Benefits Nigral D ...... e Model of Parkinson's Disease

@nl

type

Item

label

Epothilone B Benefits Nigral D ...... e Model of Parkinson's Disease

@en

Epothilone B Benefits Nigral D ...... e Model of Parkinson's Disease

@nl

prefLabel

Epothilone B Benefits Nigral D ...... e Model of Parkinson's Disease

@en

Epothilone B Benefits Nigral D ...... e Model of Parkinson's Disease

@nl

P1476

Epothilone B Benefits Nigral D ...... e Model of Parkinson's Disease

@en

P2093

Dayu Sun

http://www.w3.org/2001/XMLSchema#string

Haiwei Xu

http://www.w3.org/2001/XMLSchema#string

Ling Yang

http://www.w3.org/2001/XMLSchema#string

Siyu Chen

http://www.w3.org/2001/XMLSchema#string

Xiaotang Fan

http://www.w3.org/2001/XMLSchema#string

Yang Yang

http://www.w3.org/2001/XMLSchema#string

Zhongyuan Yu

http://www.w3.org/2001/XMLSchema#string

P2860

M1 and M2 immune activation in Parkinson's Disease: Foe and ally?

Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.

Dynamic rewiring of neural circuits in the motor cortex in mouse models of Parkinson's disease.

Axonal regeneration. Systemic administration of epothilone B promotes axon regeneration after spinal cord injury

Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective

Role of Prefrontal Serotonergic and Dopaminergic Systems in Encounter-Induced Hyperactivity in Methamphetamine-Sensitized Mice.

Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson's Disease.

Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

Targeting of the translocator protein 18 kDa (TSPO): a valuable approach for nuclear and optical imaging of activated microglia.

The role of innate and adaptive immunity in Parkinson's disease.

P304

324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNCEL.2018.00324

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30323743

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

microglia

dopamine

P932

6172330

http://www.w3.org/2001/XMLSchema#string